Multilayered Microparticles for Controlled Release of Active Compounds

ChangeBridge: Patent Apps - Pharma (A61K)

Detected March 27th, 2026

Summary

The USPTO has published a new patent application (US20260083713A1) detailing multilayered microparticles for controlled release of active compounds in liquid dosage forms. The application was filed on October 21, 2025, by inventors from Belgium.

View original document View source feed page

What changed

This document is a publication of a patent application filed with the USPTO, specifically application number US20260083713A1, titled 'Multilayered microparticles for controlled release of active compounds'. The application describes a novel microparticle technology designed for controlled release of pharmaceutically active compounds, intended for oral or direct gastric administration in liquid pharmaceutical compositions. It also covers related liquid and solid compositions, preparation kits, and manufacturing processes.

As this is a patent application publication, it does not impose immediate regulatory obligations or compliance deadlines on pharmaceutical companies. However, it signifies potential future intellectual property developments in drug delivery systems. Companies operating in the pharmaceutical manufacturing sector should be aware of this publication as it may relate to their research and development pipelines or existing patent portfolios.

Source document (simplified)

← USPTO Patent Applications

MULTILAYERED PHARMACEUTICALLY ACTIVE COMPOUND-RELEASING MICROPARTICLES IN A LIQUID DOSAGE FORM

Application US20260083713A1 Kind: A1 Mar 26, 2026

Inventors

Geoffrey DE BILDE, Pierre SACRE, Jonathan GOOLE, Karim AMIGHI, Olivier LALOUX, Georges GUILLAUME, Vincent STEPHENNE

Abstract

The present invention concerns controlled-release multilayer microparticle containing a pharmaceutically active compound, said microparticle being intended for oral administration or direct administration in the stomach in the form of a liquid pharmaceutical composition. It concerns also the liquid pharmaceutical composition containing it, a kit for the preparation of said liquid pharmaceutical composition, a pharmaceutical solid composition intended to be reconstituted in the form of said liquid composition and a process of preparation of said liquid composition.